J. E. Otterstad1, M. G. St. John Sutton2, G. S. Froeland1, I. Holme3, T. Skjærpe4 and C. Hall5 ...... [9] Otterstad JE, Froeland G, St. John Sutton MG et al. Accu-.
European Heart Journal (2002) 23, 1011–1020 doi:10.1053/euhj.2001.2969, available online at http://www.idealibrary.com on
Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction Assessment of baseline values (2–7 days) and changes at 3 months in patients with a preserved systolic function J. E. Otterstad1, M. G. St. John Sutton2, G. S. Froeland1, I. Holme3, T. Skjærpe4 and C. Hall5 1
Division of Cardiology, Vestfold Central Hospital, Toensberg, Norway; 2Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, U.S.A.; 3Institute of Medical Statistics, Ulleva˚l Hospital, Oslo, Norway; 4 Division of Cardiology, University Hospital of Trondheim, Norway; 5Research Institute for Internal Medicine, University of Oslo, Norway
Aims The purpose of this prospective, observational study was to evaluate the relationship of left ventricular volumes, systolic function and plasma N-terminal proatrial natriuretic peptide (Nt-proANP) to cardiac morbidity and mortality in post-myocardial infarction patients with left ventricular ejection fraction d40%.
volume was the strongest predictor for adverse events (chi-square 19·1, P
